Research-grade Retatrutide (LY3437943) — the most advanced triple-agonist peptide available for in-vitro research. Simultaneously targets GLP-1, GIP, and glucagon receptors, making it one of the most studied compounds in metabolic research.
Every batch independently tested by Janoshik Analytical — a leading third-party laboratory. Scan the QR code on your packaging to view the full certificate of analysis for your specific batch number.
Reconstituted fresh to order — your pen is never pre-filled or shelf-stored. Prepared upon payment confirmation and dispatched within 24–48 hours via Royal Mail Tracked.